Organisation: Patent and Trademark Office (Brazil)

Featured in The Guide to Life Sciences: Key issues for senior life sciences executives 2024

Brazil is a strategic market for many local and foreign pharmaceutical companies due to its protective legislation with regard to access to healthcare. However, its pharma ecosystem is complex and requires a comprehensive understanding of the legal framework that governs IP protection. 

24 June 2024

It is also unclear whether thousands of pending challenges will be affected by the process change

26 April 2024

Featured in SEP/FRAND Hub 2023/2024

With a large middle-class population, a pro-market government and a sizeable domestic market, Brazil already owns one of the largest markets worldwide and is becoming increasingly relevant in global patent disputes.

27 October 2023

Featured in The Guide to Life Sciences: Key issues for senior life sciences executives 2023

The reduction of the patent term for pharmaceuticals resulted in uncertainty for stakeholders in Brazil. However, new legislation designed to modernise the country’s patent system and foster the innovation ecosystem are paving the way to Brazil becoming an increasingly attractive jurisdiction.

25 August 2023

Almost 50 cases have arisen in which IP owners are asserting their rights to an extended timeframe, the outcomes of which will have major ramifications in Latin America’s largest economy

30 May 2023

Move could see ‘temporary paralysis’ at INPI

12 January 2023

Patentees may be able to avoid the loss of exclusivity created by another recent top court decision

06 December 2022